List of Contents

Multiplex Assays Market Size, Share, and Trends 2024 to 2033

Multiplex Assays Market (By Product: Consumables, Instruments, Software; By Type: Protein Multiplex Assays, Nucleic Acid Multiplex Assays, Cell-based Multiplex Assays; By Technology: Flow Cytometry, Fluorescence Detection, Luminescence, By Application: Research & Development, Clinical Diagnostics; By End-use: Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : July 2024
  • Report Code : 4627
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Multiplex Assays Market 

5.1. COVID-19 Landscape: Multiplex Assays Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Multiplex Assays Market, By Product

8.1. Multiplex Assays Market Revenue and Volume, by Product, 2024-2033

8.1.1. Consumables

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Instruments

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Software

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Multiplex Assays Market, By Type

9.1. Multiplex Assays Market Revenue and Volume, by Type, 2024-2033

9.1.1. Protein Multiplex Assays

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Nucleic Acid Multiplex Assays

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Cell-based Multiplex Assays

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Multiplex Assays Market, By Technology 

10.1. Multiplex Assays Market Revenue and Volume, by Technology, 2024-2033

10.1.1. Flow Cytometry

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Flow Cytometry

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Luminescence

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Multiplex Real-Time PCR

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

10.1.5. Other Technologies

10.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Multiplex Assays Market, By End-use

11.1. Multiplex Assays Market Revenue and Volume, by End-use, 2024-2033

11.1.1. Pharmaceutical & Biotechnology Companies

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Hospitals & Diagnostic Laboratories

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Research & Academic Institutes

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

11.1.4. Other End-users

11.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Multiplex Assays Market, By Application

12.1. Multiplex Assays Market Revenue and Volume, by Application, 2024-2033

12.1.1. Research & Development

12.1.1.1. Market Revenue and Volume Forecast (2021-2033)

12.1.2. Clinical Diagnostics

12.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 13. Global Multiplex Assays Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.1.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.1.6.5. Market Revenue and Volume Forecast, by Application (2021-2033) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.7.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.7.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.1.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.1.7.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033) 

13.2.5. Market Revenue and Volume Forecast, by Application (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.2.7. Market Revenue and Volume Forecast, by End-use (2021-2033) 

13.2.8. Market Revenue and Volume Forecast, by Application (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.9.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.9.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.2.10. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2.11. Market Revenue and Volume Forecast, by Application (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.12.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.12.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.2.12.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2.13. Market Revenue and Volume Forecast, by Application (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.14.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.14.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.2.14.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2.15. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.7. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.8.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.9. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.10.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.3.10.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.10.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.11.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.3.11.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.11.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.7. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.8.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.9. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.10.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.4.10.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.10.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.11.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.4.11.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.11.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5.5. Market Revenue and Volume Forecast, by Application (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.6.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5.7. Market Revenue and Volume Forecast, by Application (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.8.3. Market Revenue and Volume Forecast, by Technology (2021-2033)

13.5.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5.8.5. Market Revenue and Volume Forecast, by Application (2021-2033)

Chapter 14. Company Profiles

14.1. R&D Systems, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Advanced Cell Diagnostics

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Perkin Elmer Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Thermo Fischer Scientific

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. QIAGEN N.V

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Promega Connections

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Assay Genie

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Merck KGaA

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Seegene Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Abcam Plc

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client